Vaccinex Pink Sheet Forecast - Simple Regression
| VCNX Stock | USD 1.21 0.05 4.31% |
Vaccinex Pink Sheet outlook is based on your current time horizon.
At this time, The relative strength index (RSI) of Vaccinex's share price is at 56. This entails that the pink sheet is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Vaccinex, making its price go up or down. Momentum 56
Buy Extended
Oversold | Overbought |
Using Vaccinex hype-based prediction, you can estimate the value of Vaccinex from the perspective of Vaccinex response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Vaccinex on the next trading day is expected to be 1.26 with a mean absolute deviation of 0.11 and the sum of the absolute errors of 6.87. Vaccinex after-hype prediction price | USD 1.21 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Vaccinex |
Vaccinex Additional Predictive Modules
Most predictive techniques to examine Vaccinex price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vaccinex using various technical indicators. When you analyze Vaccinex charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Vaccinex Simple Regression Price Forecast For the 30th of January
Given 90 days horizon, the Simple Regression forecasted value of Vaccinex on the next trading day is expected to be 1.26 with a mean absolute deviation of 0.11, mean absolute percentage error of 0.02, and the sum of the absolute errors of 6.87.Please note that although there have been many attempts to predict Vaccinex Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Vaccinex's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Vaccinex Pink Sheet Forecast Pattern
| Backtest Vaccinex | Vaccinex Price Prediction | Buy or Sell Advice |
Vaccinex Forecasted Value
In the context of forecasting Vaccinex's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Vaccinex's downside and upside margins for the forecasting period are 0.01 and 18.15, respectively. We have considered Vaccinex's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Vaccinex pink sheet data series using in forecasting. Note that when a statistical model is used to represent Vaccinex pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.9803 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1107 |
| MAPE | Mean absolute percentage error | 0.1542 |
| SAE | Sum of the absolute errors | 6.8653 |
Predictive Modules for Vaccinex
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vaccinex. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Vaccinex After-Hype Price Density Analysis
As far as predicting the price of Vaccinex at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vaccinex or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Vaccinex, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Vaccinex Estimiated After-Hype Price Volatility
In the context of predicting Vaccinex's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vaccinex's historical news coverage. Vaccinex's after-hype downside and upside margins for the prediction period are 0.06 and 18.11, respectively. We have considered Vaccinex's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Vaccinex is out of control at this time. Analysis and calculation of next after-hype price of Vaccinex is based on 3 months time horizon.
Vaccinex Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Vaccinex is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vaccinex backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vaccinex, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.47 | 16.90 | 0.00 | 0.01 | 0 Events / Month | 1 Events / Month | Any time |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.21 | 1.21 | 0.00 |
|
Vaccinex Hype Timeline
Vaccinex is at this time traded for 1.21. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Vaccinex is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at 2.47%. %. The volatility of related hype on Vaccinex is about 754464.29%, with the expected price after the next announcement by competition of 1.20. About 51.0% of the company outstanding shares are owned by institutional investors. The company recorded earning per share (EPS) of 7.42. Vaccinex had not issued any dividends in recent years. The entity had 1:14 split on the 20th of February 2024. Given the investment horizon of 90 days the next estimated press release will be any time. Check out Historical Fundamental Analysis of Vaccinex to cross-verify your projections.Vaccinex Related Hype Analysis
Having access to credible news sources related to Vaccinex's direct competition is more important than ever and may enhance your ability to predict Vaccinex's future price movements. Getting to know how Vaccinex's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vaccinex may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MDGEF | Medigene AG | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NBCO | Neon Bloom | (0.01) | 1 per month | 3.49 | 0.06 | 13.70 | (5.19) | 40.26 | |
| ENZC | Enzolytics | (0.0002) | 2 per month | 15.23 | 0.15 | 50.00 | (33.33) | 133.33 | |
| CAIHF | Chia Tai Enterprises | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BMNDF | Biomind Labs | (0.02) | 1 per month | 0.00 | 0.13 | 0.00 | 0.00 | 443.04 | |
| EVFM | Evofem Biosciences | 0.00 | 0 per month | 6.60 | 0.02 | 20.00 | (16.67) | 51.52 | |
| BICTF | Biocure Technology | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GRTX | Galera Therapeutics | 0.00 | 0 per month | 5.75 | 0 | 13.64 | (10.55) | 34.53 | |
| UNBX | Unity Biotechnology | 0.00 | 0 per month | 11.01 | 0 | 22.58 | (17.00) | 87.87 | |
| CNNA | Cann American Corp | 0.00 | 1 per month | 19.63 | 0.17 | 66.67 | (40.00) | 2,040 |
Other Forecasting Options for Vaccinex
For every potential investor in Vaccinex, whether a beginner or expert, Vaccinex's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Vaccinex Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Vaccinex. Basic forecasting techniques help filter out the noise by identifying Vaccinex's price trends.Vaccinex Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vaccinex pink sheet to make a market-neutral strategy. Peer analysis of Vaccinex could also be used in its relative valuation, which is a method of valuing Vaccinex by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Vaccinex Market Strength Events
Market strength indicators help investors to evaluate how Vaccinex pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vaccinex shares will generate the highest return on investment. By undertsting and applying Vaccinex pink sheet market strength indicators, traders can identify Vaccinex entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.04 | |||
| Day Median Price | 1.21 | |||
| Day Typical Price | 1.21 | |||
| Price Action Indicator | 0.025 | |||
| Period Momentum Indicator | 0.05 | |||
| Relative Strength Index | 56.28 |
Vaccinex Risk Indicators
The analysis of Vaccinex's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Vaccinex's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting vaccinex pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 9.89 | |||
| Semi Deviation | 12.19 | |||
| Standard Deviation | 16.38 | |||
| Variance | 268.27 | |||
| Downside Variance | 307.71 | |||
| Semi Variance | 148.52 | |||
| Expected Short fall | (12.54) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Vaccinex
The number of cover stories for Vaccinex depends on current market conditions and Vaccinex's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vaccinex is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vaccinex's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Vaccinex Short Properties
Vaccinex's future price predictability will typically decrease when Vaccinex's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vaccinex often depends not only on the future outlook of the potential Vaccinex's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vaccinex's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 463.6 K | |
| Cash And Short Term Investments | 1.5 M |
Additional Tools for Vaccinex Pink Sheet Analysis
When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.